📣 VC round data is live. Check it out!
- Public Comps
- MRSO
MRSO Valuation Multiples
Discover revenue and EBITDA valuation multiples for MRSO and similar public comparables like Beamtree, EBM Technologies, Diagnos, NextPlat and more.
MRSO Overview
About MRSO
MRSO Inc operates a healthcare platform and provides vertical SaaS solutions for medical institutions, government entities, and corporations. The company offers a preventive medical platform that enables reservations for medical checkups and various cancer screenings. It also provides administrative DX services that support tasks carried out by local governments, including the acceptance of reservations for resident health checkups and vaccinations. These administrative DX services are used by local governments across regions with varying population sizes.
Founded
2015
HQ

Employees
24
Website
Financials (LTM)
EV
$8M
Valuation Multiples
Start free trialMRSO Financials
MRSO reported last 12-month revenue of $7M.
In the same LTM period, MRSO generated had net loss of ($150K).
Revenue (LTM)
MRSO P&L
In the most recent fiscal year, MRSO reported revenue of $7M and EBITDA of ($185K).
MRSO is unprofitable as of last fiscal year, with gross margin of 73%, EBITDA margin of (3%), and net margin of (2%).
Financial data powered by Morningstar, Inc.
MRSO Stock Performance
MRSO has current market cap of $19M, and enterprise value of $8M.
Market Cap Evolution
MRSO's stock price is $5.40.
MRSO share price decreased by 0.5% in the last 30 days, and by 13.6% in the last year.
MRSO has an EPS (earnings per share) of $-0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8M | $19M | -0.5% | -0.5% | -3.8% | -13.6% | $-0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMRSO Valuation Multiples
MRSO trades at 1.2x EV/Revenue multiple, and (45.6x) EV/EBITDA.
EV / Revenue (LTM)
MRSO Financial Valuation Multiples
As of June 2, 2026, MRSO has market cap of $19M and EV of $8M.
MRSO has a P/E ratio of (126.2x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified MRSO Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


MRSO Margins & Growth Rates
In the most recent fiscal year, MRSO reported gross margin of 73%, EBITDA margin of (3%), and net margin of (2%).
MRSO Margins
MRSO Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
MRSO Operational KPIs
MRSO's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
MRSO Competitors
MRSO competitors include Beamtree, EBM Technologies, Diagnos, NextPlat, CareView Communications, Proteomics, CurveBeam AI, Metacare, Cambridge Cognition and MedApp.
Most MRSO public comparables operate across Healthcare Software, Health Data & Analytics, B2B SaaS, Vertical SaaS and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.9x | 1.2x | (84.3x) | (84.3x) | |||
| 2.1x | - | 18.9x | - | |||
| 249.7x | - | (7.3x) | - | |||
| 0.2x | - | (0.9x) | - | |||
| - | - | - | - | |||
| 5.3x | 5.3x | (2.5x) | (2.5x) | |||
| 3.0x | 3.3x | (3.6x) | (3.6x) | |||
| 2.2x | - | 13.2x | - | |||
This data is available for Pro users. Sign up to see all MRSO competitors and their valuation data. Start Free Trial | ||||||
MRSO VC Funding History
Before going public, MRSO raised $3M in total equity funding, across 1 round.
MRSO Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout MRSO
| When was MRSO founded? | MRSO was founded in 2015. |
| Where is MRSO headquartered? | MRSO is headquartered in Japan. |
| How many employees does MRSO have? | As of today, MRSO has over 24 employees. |
| Is MRSO publicly listed? | Yes, MRSO is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of MRSO? | MRSO trades under 5619 ticker. |
| When did MRSO go public? | MRSO went public in 2023. |
| Who are competitors of MRSO? | MRSO main competitors include Beamtree, EBM Technologies, Diagnos, NextPlat, CareView Communications, Proteomics, CurveBeam AI, Metacare, Cambridge Cognition, MedApp. |
| What is the current market cap of MRSO? | MRSO's current market cap is $19M. |
| What is the current revenue of MRSO? | MRSO's last 12 months revenue is $7M. |
| What is the current EV/Revenue multiple of MRSO? | Current revenue multiple of MRSO is 1.2x. |
| Is MRSO profitable? | No, MRSO is not profitable. |
| What is the current net income of MRSO? | MRSO's last 12 months net income is ($150K). |
| How many companies MRSO has acquired to date? | MRSO hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies MRSO has invested to date? | MRSO hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to MRSO
Lists including MRSO
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.